Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine dose comparison for pediatric ophthalmology outpatient examination sedation
ChiCTR1800014417Phase 4Not yet recruiting
- Sponsor
- Eye Hospital of Wenzhou Medical University
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in procedural sedation and analgesia (PSA) (2 arms), sponsored by Eye Hospital of Wenzhou Medical University. Primary endpoints: Examination success rate, Eye position quality and 2 more. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
procedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on ChiCTR1800014417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014417.